CT and MRI of abdominal cancers: current trends and perspectives in the era of radiomics and artificial intelligence
- PMID: 37926780
- DOI: 10.1007/s11604-023-01504-0
CT and MRI of abdominal cancers: current trends and perspectives in the era of radiomics and artificial intelligence
Abstract
Abdominal cancers continue to pose daily challenges to clinicians, radiologists and researchers. These challenges are faced at each stage of abdominal cancer management, including early detection, accurate characterization, precise assessment of tumor spread, preoperative planning when surgery is anticipated, prediction of tumor aggressiveness, response to therapy, and detection of recurrence. Technical advances in medical imaging, often in combination with imaging biomarkers, show great promise in addressing such challenges. Information extracted from imaging datasets owing to the application of radiomics can be used to further improve the diagnostic capabilities of imaging. However, the analysis of the huge amount of data provided by these advances is a difficult task in daily practice. Artificial intelligence has the potential to help radiologists in all these challenges. Notably, the applications of AI in the field of abdominal cancers are expanding and now include diverse approaches for cancer detection, diagnosis and classification, genomics and detection of genetic alterations, analysis of tumor microenvironment, identification of predictive biomarkers and follow-up. However, AI currently has some limitations that need further refinement for implementation in the clinical setting. This review article sums up recent advances in imaging of abdominal cancers in the field of image/data acquisition, tumor detection, tumor characterization, prognosis, and treatment response evaluation.
Keywords: Abdominal cancer; Artificial intelligence; Diagnostic imaging; Machine learning; Oncology; Precision medicine.
© 2023. The Author(s) under exclusive licence to Japan Radiological Society.
Similar articles
-
[Progress in Precision Medicine of Radiomics in Abdominal Tumors Practice].Zhongguo Yi Liao Qi Xie Za Zhi. 2022 Mar 30;46(2):187-190. doi: 10.3969/j.issn.1671-7104.2022.02.015. Zhongguo Yi Liao Qi Xie Za Zhi. 2022. PMID: 35411748 Chinese.
-
Artificial Intelligence-Driven Radiomics in Head and Neck Cancer: Current Status and Future Prospects.Int J Med Inform. 2024 Aug;188:105464. doi: 10.1016/j.ijmedinf.2024.105464. Epub 2024 Apr 23. Int J Med Inform. 2024. PMID: 38728812 Review.
-
MRI-Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges.J Magn Reson Imaging. 2024 Mar;59(3):767-783. doi: 10.1002/jmri.28982. Epub 2023 Aug 30. J Magn Reson Imaging. 2024. PMID: 37647155 Review.
-
Imaging of Pancreatic Ductal Adenocarcinoma: An Update on Recent Advances.Can Assoc Radiol J. 2023 May;74(2):351-361. doi: 10.1177/08465371221124927. Epub 2022 Sep 5. Can Assoc Radiol J. 2023. PMID: 36065572 Review.
-
Artificial intelligence in the interpretation of breast cancer on MRI.J Magn Reson Imaging. 2020 May;51(5):1310-1324. doi: 10.1002/jmri.26878. Epub 2019 Jul 25. J Magn Reson Imaging. 2020. PMID: 31343790 Review.
References
-
- Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current challenges in cancer treatment. Clin Ther. 2016;38(7):1551–66. - PubMed
-
- Tzedakis S, Sindayigaya R, Dhote A, Marchese U, Barret M, Belle A, et al. Perihilar cholangiocarcinoma: what the radiologist needs to know. Diagn Interv Imaging. 2022;103(6):288–301. - PubMed
-
- Pellat A, Barat M, Coriat R, Soyer P, Dohan A. Artificial intelligence: a review of current applications in hepatocellular carcinoma imaging. Diagn Interv Imaging. 2023;104(1):24–36. - PubMed
-
- Xue C, Zhou Q, Xi H, Zhou J. Radiomics: a review of current applications and possibilities in the assessment of tumor microenvironment. Diagn Interv Imaging. 2023;104(3):113–22. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources